mirtazapine has been researched along with Essential Tremor in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Essential Tremor: A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families (i.e., familial tremor). (Mov Disord 1988;13(1):5-10)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We sought to determine whether mirtazapine is safe and well-tolerated as a treatment for essential tremor (ET)." | 9.10 | Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. ( Lyons, KE; Pahwa, R, 2003) |
| "We sought to determine whether mirtazapine is safe and well-tolerated as a treatment for essential tremor (ET)." | 5.10 | Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. ( Lyons, KE; Pahwa, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pahwa, R | 1 |
| Lyons, KE | 1 |
1 trial available for mirtazapine and Essential Tremor
| Article | Year |
|---|---|
Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study.
Topics: Aged; Antidepressive Agents, Tricyclic; Cross-Over Studies; Double-Blind Method; Essential Tremor; F | 2003 |